Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, TRI

Hyperbaric Oxygen Therapy Shows Promise in Addressing Long COVID Pathophysiology, According to Clinical Review Authored by Hyperbaric Medical Solutions Directors


A groundbreaking clinical review published in Frontiers in Medicine reveals promising findings on the effectiveness of hyperbaric oxygen therapy (HBOT) in addressing the pathophysiology of long COVID.

WOODBURY, N.Y., Feb. 22, 2024 /PRNewswire-PRWeb/ -- A groundbreaking clinical review published in Frontiers in Medicine reveals promising findings on the effectiveness of hyperbaric oxygen therapy (HBOT) in addressing the pathophysiology of long COVID. The study, titled "Hyperbaric Oxygen Effectively Addresses the Pathophysiology of Long COVID: Clinical Review," was authored by the National Medical Director, and the New England Clinical Director of Hyperbaric Medical Solutions, alongside three other esteemed researchers.

"This new research concludes that HBOT is a safe and beneficial treatment for patients suffering from long COVID. It is my hope that this research encourages all medical providers, who encounter patients with long COVID symptoms, to refer patients for HBOT." - Alan A. Katz, MD

The research team, led by Dr. Alan Katz, National Medical Director of Hyperbaric Medical Solutions, and Dr. Rosemary Byrne, New England Medical Director of the same institution, collaborated with three other prominent experts in the field to explore the potential benefits of HBOT in mitigating the lingering effects of the COVID-19 virus.

Hyperbaric Medical Solutions, a leading provider of hyperbaric oxygen therapy, has been at the forefront of treating long COVID patients with positive outcomes. The research builds upon the institution's commitment to advancing medical knowledge and improving patient outcomes through hyperbaric oxygen and other regenerative medicine therapies.

Key findings from the clinical review include:

Dr. Alan Katz commented on the significance of the findings, stating, "This study opens new avenues for exploring hyperbaric oxygen therapy as a potential intervention for long COVID. The positive outcomes observed in our clinical review highlight the need for further research and clinical trials to validate these promising results."

Hyperbaric Medical Solutions remains committed to advancing the understanding and treatment of long COVID. The institution looks forward to continuing its successful treatment of long COVID patients and contributing to the ongoing efforts to address the global impact of the pandemic.

For further information or to request interviews with the research team, please contact:

Dr. Alan Katz

Hyperbaric Medical Solutions

80 Crossways Park Drive

Woodbury, NY 11797

516-774-2747

[email protected]

https://www.hyperbaricmedicalsolutions.com/

About Hyperbaric Medical Solutions:

Hyperbaric Medical Solutions is a leading provider of hyperbaric oxygen therapy, committed to advancing medical knowledge and improving patient outcomes through innovative therapies. With the National Medical Director and New England Medical Director co-authoring the recent clinical review, Hyperbaric Medical Solutions continues to be at the forefront of research and treatment for long COVID.

Media Contact

Alan A. Katz, Hyperbaric Medical Solutions, 1 516-774-2747, [email protected], https://www.hyperbaricmedicalsolutions.com/

SOURCE Hyperbaric Medical Solutions


These press releases may also interest you

at 11:10
The "Small Wind - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Small Wind Market to Reach $2.3 Billion by 2030 The global market for Small Wind estimated at US$1.2 Billion in the year 2023,...

at 11:00
Hyatt Hotels Corporation announced The Bentley Hotel Southampton has officially joined the Hyatt portfolio as an affiliated hotel, in collaboration with Bijal Hospitality, the property's owner and operator. The hotel, which is currently in the midst...

at 10:55
The "Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The global interventional pulmonology market is forecasted to reach...

at 10:50
The "Global TDI & MDI Market (By End User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The global TDI market is forecasted to reach US$8.50 billion in...

at 10:25
The "Global Cathode Materials Market (by Material, Battery Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The global cathode materials...

at 10:20
The "Global Power Tools Market (by Mode of Operation, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The global power tools market is expected to...



News published on and distributed by: